Stories

FDA chief touts more approvals of generic drugs

FDA Commissioner Scott Gottlieb prepares to testify on Capitol Hill. Photo: Drew Angerer/Getty Images

The Food and Drug Administration has dramatically cut down its backlog of generic drugs waiting for an approval decision — a long-standing but elusive goal with the potential to help lower consumers' drug costs.

What they're saying: "I think the greatest opportunity to have a very palpable impact on people's lives is through trying to create greater access," FDA Commissioner Scott Gottlieb said in an interview with The Washington Post. "The low-hanging fruit was on the generic drug side."